Pharmaceutical
Home » Precision Medicine Market

Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2023

Price: $4999

Published: | Report ID: 11123 | Category: Pharmaceuticals

Market Insights

This report, titled “Precision Medicine Market,” studies various technology types, application types, and geographical scenarios. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and build a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease. Both components are now within reach because of advances in basic research, including molecular biology, genomics, and bioinformatics.

For this study, the global precision medicine market is segmented based on technology type into companion diagnostics, gene sequencing, drug discovery, big data analytics, bioinformatics, and 3D printing. Market size estimates and forecasts for these segments for 2013–2022 are provided in terms of USD million along with the respective compounded annual growth rates (CAGRs) for 2016–2022, considering 2015 as the base year.

For this study, the global precision medicine market is segmented based on application type into oncology, cardiovascular diseases, central nervous system diseases, infectious diseases, and others. Market size estimates and forecasts for these segments for 2013–2022 are provided in terms of USD million along with the respective compounded annual growth rates (CAGRs) for the period 2016–2022, considering 2015 as the base year.

The precision medicine market has been geographically categorised into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, Brazil, and the GCC countries. The market size and forecast for these segments during 2013–2022 and their CAGRs for the period 2016–2022 are provided in this report.

The major key players profiled in the precision medicine market are based on various characteristics such as business description, financial health, budget allocation, product portfolio, and news coverage. The key players profiled in this report are Biocrates Life Sciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Ferrer InCode, Abbott Laboratories, Almac Group, Ltd., bioMérieux SA, Covance, Silicon Biosystems (now part of the Menarini Group), Pfizer, Eagle Genomics, Source Precision Medicine, Inc., Laboratory Corporation of America Holdings, Medtronics, Novartis, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and others.

Based on the type of application, the global precision medicine market is segmented as follows:

  • Oncolog
  • Cardiovascular Diseases
  • Central Nervous System
  • Infectious Diseases
  • Others

In the base year 2015, oncology was observed as the largest market and is expected to maintain its dominance throughout the forecast period of – 2023. The key factors assisting the oncology application market are the rising prevalence of cancers, high public awareness related to the early diagnosis of the disease, and rising acceptance and demand for novel and premium cancer treatments. Market experts suggest that there have been significant advancements in breast cancer and other related cancers globally. The key improvements were observed, such as predictive biomarkers in lung cancer therapy that target receptors such as c-ros oncogene one receptor tyrosine kinase (ROS1), epidermal growth factor receptor (EGFR), immune checkpoints, and anaplastic lymphoma kinase (ALK). In oncology, cancer genomics is expected to advance personalized medicine through DNA sequencing and analysis of patient tumors to find new genetic alterations associated with specific cancers. This technology will provide researchers with a range of comprehensive catalogs of the fundamental genomic changes occurring in several major types and subtypes of cancer and ultimately support future assistance in developing more effective ways to diagnose, treat, and prevent cancer.

Based on the type of technology, the global precision medicine market is segmented as follows:

  • Companion Diagnostic
  • Gene Sequencing
  • Drug Discovery
  • Big Data Analytics
  • Bio Informatics
  • 3D Printing

In 2015, gene sequencing was observed as the largest market segment due to its high potential to improve patient care by providing vital information to physicians, such as disease risk prediction, diagnoses, and medical treatment plans. Gene sequencing is expected to develop and contribute towards an era of precision medicine where we will require an accurate account of each patient’s genetic code. The overall market growth of precision medicine is gaining pace due to a large number of government initiatives and research and development programs launched in recent years, accompanied by increasing awareness and demand related to personalized treatment. Genomic information has begun its journey to shape the development and use of some novel oncology treatments. For example, imatinib (Gleevec) has been designed to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenous leukemia. Another example is the breast cancer drug trastuzumab (Herceptin), which works only for women whose tumors have a particular genetic profile called HER-2 positivity. Thus, gene sequencing and drug discovery technologies were observed as the most significant technology segments in the precision medicine market apart from other sub-segments.

For this study, the global precision medicine market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In 2015, North America was observed as the largest and most potential regional market for precision medicine. North America comprises the regional markets of the U.S. and Canada. The rising prevalence of cancer and the support of the White House are significant drivers for the growth of the North American precision medicine market. In addition, the developed healthcare infrastructure, high public awareness related to cancer diagnosis and treatment, and rising research and development activities related to precision medicine are the key factors assisting the growth of the North American precision medicine market. The 2016 President’s Budget included USD 215 million for the Precision Medicine Initiative, which will pioneer a new model of patient-powered research that will accelerate research and development activities.

Asia Pacific and Europe are expected to be the fastest-growing regional markets for the precision medicine market by 2023. Over the next six years, the market’s growth in the Asia-Pacific region is likely to be centered in China and Japan. Several factors, such as initiatives from the government and contributions from academic laboratories, are expected to assist the growth of the Asia-Pacific market. In June 2016, BGI and Clearbridge BioMedics partnered to develop the China CTC liquid biopsy market toward precision medicine. The market experts suggest that BGI set up a dedicated team to ensure this trans-omics science and technology is effectively translated into precision medicine. This team will provide an innovative end-to-end solution for omics analysis or genetic profiling at the single-cell level from scarce cells in clinical samples.

Chapter 1 Preface 10
1.1 Report Description 10
1.1.1 Purpose of the Report 10
1.1.2 Target Audience 10
1.1.3 USP and Key Offerings 10
1.2 Research Scope 11
1.3 Research Methodology 12
1.3.1 Phase I – Secondary Research 12
1.3.2 Phase II – Primary Research 13
1.3.3 Phase III – Expert Panel Review 13
1.3.4 Assumptions 14

Chapter 2 Executive Summary 15
2.1 Global Precision Medicine Market, by Technology Type, 2015 v/s 2023 (Value %) 16
2.2 Global Precision Medicine Market, by Application Type, 2015 (USD Mn) 17
2.3 Global Precision Medicine Market, by Geography, 2015 (Value %) 17

Chapter 3 Global Precision Medicine Market Overview 20
3.1 Overview 20
3.2 Market Drivers 20
3.3 Market Restraints 22
3.4 Market Opportunities 23
3.5 Attractive Investment Proposition 23
3.6 Market Competition Assessment: Precision Medicine, by Key Players 25

Chapter 4 Global Precision Medicine Market Analysis, By Technology Type 27
4.1 Overview 27
4.2 Companion Diagnostics 28
4.3 Gene Sequencing 29
4.4 Drug Discovery 31
4.5 Big Data Analytics 32
4.6 Bio Informatics 33
4.7 3D Printing 35

Chapter 5 Global Precision Medicine Market Analysis, By Applications 37
5.1 Overview 37
5.2 Oncology 38
5.3 Cardiovascular Diseases 39
5.4 Central Nervous System 40
5.5 Infectious Diseases 40
5.6 Others Diseases 40

Chapter 6 Global Precision Medicine ion Market, By Geography 42
6.1 Preface 42
6.2 North America 43
6.3 Europe 44
6.4 Asia Pacific 46
6.5 Latin America 47
6.6 Middle East and Africa 49

Chapter 7 Company Profiles 51
7.1 Biocrates Life Sciences 51
7.1.1 Biocrates Life Sciences: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 51
7.2 Nanostring Technologies 52
7.2.1 Nanostring Technologies: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 52
7.3 Tepnel Pharma Services 53
7.3.1 Tepnel Pharma Services: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 53
7.4 Intomics, Ferrer InCode 54
7.4.1 Intomics, Ferrer InCode: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 54
7.5 Abbott Laboratories 55
7.5.1 Abbott Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 55
7.6 Almac Group, Ltd. 57
7.6.1 Almac Group, Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 57
7.7 bioMérieux SA 58
7.7.1 bioMérieux SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 58
7.8 Covance 59
7.8.1 Covance: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 59
7.9 Menarini Group 60
7.9.1 Menarini Group: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 60
7.10 Pfizer 61
7.10.1 Pfizer: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 61
7.11 Eagle Genomics, Source Precision Medicine, Inc. 63
7.11.1 Eagle Genomics, Source Precision Medicine, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 63
7.12 Laboratory Corporation of America Holdings 64
7.12.1 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 64
7.13 Medtronics 65
7.13.1 Medtronics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 65
7.14 Novartis 66
7.14.1 Novartis: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 66
7.15 Qiagen 67
7.15.1 Qiagen: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.16 Quest Diagnostics 67
7.16.1 Quest Diagnostics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.17 Roche Holding 67
7.17.1 Roche Holding: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
7.18 Teva Pharmaceuticals 68
7.18.1 Teva Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 68

List Of Figure

FIG. 1 Precision Medicine Market: Research Methodology 12
FIG. 2 Global Precision Medicine Market, by Technology Type, 2015 v/s 2023 (Value %) 16
FIG. 3 Global Precision Medicine Market, by Application Type, 2015 (USD Mn) 17
FIG. 4 Global Precision Medicine Market, by Geography, 2015 (Value %) 17
FIG. 5 Attractive Investment Proposition, by Geography, 2015 24
FIG. 6 Companion Diagnostics Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 29
FIG. 7 Gene Sequencing Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 30
FIG. 8 Drug Discovery Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 31
FIG. 9 Big Data Analytics Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 33
FIG. 10 Bio Informatics Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 34
FIG. 11 3D Printing Technology Market in Precision Medicine, 2013 – 2023 (USD Mn) 35
FIG. 12 Precision Medicine Application Market in Oncology, 2013 – 2023 (USD Mn) 39
FIG. 13 Precision Medicine Application Market in Cardiovascular Diseases, 2013 – 2023 (USD Mn) 39
FIG. 14 Precision Medicine Application Market in Central Nervous System, 2013 – 2023 (USD Mn) 40
FIG. 15 Precision Medicine Application Market in Infectious Diseases, 2013 – 2023 (USD Mn) 40
FIG. 16 Precision Medicine Application Market in Other Diseases, 2013 – 2023 (USD Mn) 41
FIG. 17 North America Precision Medicine Market , 2013 – 2023 (USD Mn) 44
FIG. 18 Europe Precision Medicine Market , 2013 – 2023 (USD Mn) 45
FIG. 19 Asia-Pacific Precision Medicine Market , 2013 – 2023 (USD Mn) 47
FIG. 20 Latin America Precision Medicine Market , 2013 – 2023 (USD Mn) 48
FIG. 21 Middle East and Africa Precision Medicine Market , 2013 – 2023 (USD Mn) 50

List Of Table

TABLE 1 Market Competition Assessment: Precision Medicine , by Key Players 25
TABLE 2 Global Precision Medicine Market, by Technology Type, 2013-2023 (USD Mn) 28
TABLE 3 Global Precision Medicine Market, by Applications, 2013-2023 (USD Mn) 37
TABLE 4 Global Precision Medicine Market, by Geography, 2013 – 2023 (USD Mn) 43
TABLE 5 Biocrates Life Sciences: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 51
TABLE 6 Nanostring Technologies: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 52
TABLE 7 Tepnel Pharma Services: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 53
TABLE 8 Intomics, Ferrer InCode: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 54
TABLE 9 Abbott Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 55
TABLE 10 Almac Group, Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 57
TABLE 11 bioMérieux SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 58
TABLE 12 Covance: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 59
TABLE 13 Menarini Group: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 60
TABLE 14 Pfizer: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 61
TABLE 15 Eagle Genomics, Source Precision Medicine, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 63
TABLE 16 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 64
TABLE 17 Medtronics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 65
TABLE 18 Novartis: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 66
TABLE 19 Qiagen: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 20 Quest Diagnostics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 21 Roche Holding: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 22 Teva Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 68

Frequently Asked Questions

What is the size of Precision Medicine Market?

The market for Precision Medicine Market is expected to reach XX Bn in 2023.

What is the Precision Medicine Market CAGR?

The Precision Medicine Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Precision Medicine Market?

The report is forecasted from 2016-2023.

What is the base year considered for Precision Medicine Market?

The base year of this report is 2015.

Who are the major players in this market?

Biocrates Life Sciences 51,Nanostring Technologies 52,Tepnel Pharma Services 53,Intomics, Ferrer InCode 54,Abbott Laboratories 55 are some of the major players in the global market.

Healthcare

Vietnam ECG Equipment Market

Published:
Report ID: 30632

Healthcare

Qatar Dental Care Market

Published:
Report ID: 30608

Healthcare

Caustic Soda Market

Published:
Report ID: 30586

Healthcare

Patient Engagement Solutions Market

Published:
Report ID: 8852

Healthcare

Canada Robotic Surgery Services Market

Published:
Report ID: 30554

HealthCare

Australian Medical Oxygen Concentrators Market

Published:
Report ID: 30511

Healthcare

Canada Pharmaceuticals Market

Published:
Report ID: 30503

Healthcare

Empty Capsules Market

Published:
Report ID: 30496

Vietnam Healthcare Mobility Solutions Market

Saudi Arabia Health and Medical Insurance Market

Published:
Report ID: 30435

Healthcare

Europe Telemedicine Market

Published:
Report ID: 28211

Healthcare

Europe Parenteral Nutrition Market

Published:
Report ID: 27007

Healthcare

Kids Food Supplements Market

Published:
Report ID: 25001

Purchase Options

Buy With Trust, Competitive Pricing - In-depth Analysis

$2999

Delivery Format: Excel.

$4999

Designed for the individual purchaser.

$6999

Users located at a single corporate site or regional office.

$9999

Allowed for unlimited sharing globally within one company.


Still Not Sure?

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
WhatsApp Now